AbCellera Biologics Inc (NASDAQ: ABCL) open the trading on Wednesday, with a bit cautious approach as it glided -7.62% to $3.03, before settling in for
On Friday, AbCellera Biologics Inc (NASDAQ: ABCL) was 3.30% up from the session before settling in for the closing price of $3.03. A 52-week range
Witnessing the stock’s movement on the chart, on Tuesday, AbCellera Biologics Inc (NASDAQ: ABCL) set off with pace as it heaved 3.90% to $2.93, before
AbCellera Biologics Inc (NASDAQ: ABCL) kicked off on Friday, down -1.32% from the previous trading day, before settling in for the closing price of $3.03.
AbCellera Biologics Inc (NASDAQ: ABCL) started the day on Tuesday, with a price increase of 1.03% at $2.95, before settling in for the price of
AbCellera Biologics Inc (NASDAQ: ABCL) established initial surge of 0.74% at $2.71, before settling in for the price of $2.69 at the close. Taking a
AbCellera Biologics Inc (NASDAQ: ABCL) on Friday, plunged -4.75% from the previous trading day, before settling in for the closing price of $2.95. Within the
As on Wednesday, AbCellera Biologics Inc (NASDAQ: ABCL) started slowly as it slid -3.64% to $2.91, before settling in for the price of $3.02 at
AbCellera Biologics Inc (NASDAQ: ABCL) kicked off on Tuesday, down -3.96% from the previous trading day, before settling in for the closing price of $3.03.
AbCellera Biologics Inc (NASDAQ: ABCL) started the day on Wednesday, with a price increase of 6.01% at $3.00, before settling in for the price of
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
